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Brainwork
It has taken science some two thousand years to recognize the
brain as the master organ of the body-the locus of thought,
the seat of the emotions, the governor of behavior. The gradual
discovery of the brain's architecture and its billions of nerve
cells has inspired such analogies as electrical switchboards and
supercomputers. Only in the past thirty years have scientists
begun to evolve a more subtle concept of the brain. In this
view, electrical signals are transmitred from one nerve cell to
another by chemical molecules released at the junction-or
synapse-between two cells. Scientists have also begun to learn
how nerve cells react to and are altered in crucial ways by other
chemical messengers called hormones.
The word hormone means "to set in motion," although, in
fact, hormones can also inhibit the response of cells they affect.
Among the most potent and specific hormones are the steroids,
the subjects of study in Donald Pfaff's laboratory of neurobiology
and behavior at The Rockefeller University. Steroid hormones
include those that control the response to stress and the so-called
sex steroids. Sex steroids include the androgens (controllers of
sperm production), the estrogens (regulators of the menstrual
cycle), and progesterone (which helps to prepare the uterus for
ovulation).
Donald W. Pfaff
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Postdoctoral Fellow Robert Gibbs
is studying genes involved in the
growth andmaintenance ofnerve
cells. He recently employed new
DNA probe techniques to analyze
the receptors in the brain for
Nerve Growth Factor. Now he is
contrastingpatterns ofexpression,
between uterus and brain, for a
cancer-related gene, c-fos.
Some hormones are secreted into the bloodstream by endo-
crine glands; some originate in the brain itself. Acting on nerve
cells in the portion of the brain called the hypothalamus and
in the spinal cord, these chemical messengers bring about sex-
related physical changes in developing animals and humans,
affect such behaviors as feeding, mating, and aggressiveness,
and influence moods and other mental states.
Donald Pfaff began thinking about brain hormones in his
graduate school days in the 1960s, when not very much was
known about them. Today, Dr. Pfaff and his team of researchers,
using a wide variety of research techniques, are manipulating
hormones and other chemical molecules to uncover how the
brain works.
FROM BRAIN TO BEHAVIOR
After graduating from Harvard College in 1961, Don Pfaff
decided to forego a family tradition in surgery to enter a new
brain research program at the Massachusetts Institute of Tech-
nology. In late 1961, when he was exploring ideas for his Ph.D.,
his thesis advisor, neurobiologist Joseph Altman, mentioned in
passing that he would "like to do something with hormones."
His student was intrigued and began reading up on them. He
learned that some behaviors are controlled by the brain and are
specifically dependent on hormonal chemicals carried by the
blood to target tissues all over the body.
Today, it is known that for a hormone to work it must fit
and bind to a specifically shaped receptor molecule jutting out
from the membrane of a target cell or embedded in its nucleus.
But in the early '60s nothing was known about the existence
of receptor sites on cells to which hormone molecules could
bind and subsequently activate.
Dr. Pfaff's initial efforts to understand hormone activity in
the brain had two fortuitous boosts. In 1962 researchers at the
University of Chicago reported the first proof of steroid receptors
in other cells in the body. Just about the same time, a dtug
company in Boston began manufacturing the first radioactively
labeled estrogens. Dr. Pfaff decided to use these radioactive
estrogens to locate hormone receptors in the brain. "So," he
recalls, "I got into my car, crossed the Charles River, and got
some."
By preparing sections of nerve-cell tissue treated with these
radioactive estrogens and a special photographic emulsion, he
hoped it would be possible to detect where the hormone
molecules attached on the cell. Sure enough, the new procedure
revealed clusters of tiny grains-due to the radioactive estrogens
-wherever the hormone molecules had collected.
As it turned out, he and his colleagues at MIT and later at
the Rockefeller, where he began his postdoctoral studies in
1966, were able to prove that steroid hormone binding occurs
in all vertebrate brains from fish and amphibians to reptiles,
birds, and mammals. The patterns and mechanisms of binding
by estrogens, androgens, progesterone, and the stress hormones
(glucocorticoids and mineralcorticoids) appear to be universal.
That hormones and their receptors are similar in many different
organisms is a major theme in the lab's work because, as Dr.
Pfaff says, "we are interested in those things that you can
discover in an animal brain that would also be true in a human
brain. "
"As we were reinforced by the positive findings," he adds,
"we began to say, :Aha. We have hit an island of knowledge
here. How large is it?' It's like the Dutch discovering Australia:
they didn't realize it was a continent, otherwise they would
have stayed." Dr. Pfaff stayed, and he and his fellow neuro-
biologists are still exploring their continent: mechanisms of
hormone action.
The mapping by Dr. Pfaff and others of steroid-binding sites
in the hypothalamus and related areas of the brain made it
possible to work Out, for the first time, the neural circuit for
a mammalian behavior. The model was the hormone-dependent
mating behavior of the female rat.
When prompted by the sex hormone estradiol, a form of
estrogen that acts on nerve cells in the brain, the female rat
responds to physical stimuli from the male on her flanks and
rear by assuming a posture-the lordosis reflex-that allows
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mating. Estradiol must be present in the female brain for the
stimulation to elicit the mating response. Dr. Pfaff and his
colleagues have correlated their hormonal receptOr data with
measures of electrical activity in steroid-binding neurons and
analyses of sensory and motor mechanisms. "The power of the
hormone effect," he notes, "is like a key that allows us to open
the gateway to an entire circuit, from brain to behavior, and
to analyze it."
Currently, the lab studies gene expression for the hormone
receptors themselves. By showing that estrogen turns on the
gene for the progesterone receptor, the researchers related, for
the first time, a gene transcription factor to a behavior.
GENE AND PROTEIN EXPRESSION
Hormonal control of neurons has proved to be a powerful model
for other kinds of experiments. Charles Mobbs is using it to
explore the biochemical mechanisms by which steroids regulate
the functioning of nerve cell connections in the brain. Very
little is known abour these mechanisms, though they are be-
lieved to be relevant not only to basic neurobiological processes
bur also to many clinical impairments. One question under
investigation is whether, during reproductive senescence, the
hormone could cause selective loss of neural synaptic hookups
that it once facilitated.
Scientists have found that steroids can trigger receptors in
the cell nucleus that, in turn, switch on certain genes controlling
production of specific polypeptides or proteins. On the basis of
this and other data, Drs. Pfaff and Mobbs theorize that estradiol
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induces the synthesis of proteins in the hypothalamus, some
of which are then transporred to the midbrain. From there these
proteins may activate working connections between sensory and
motor neurons governing contractions of the muscles involved
in specific behaviors. The identification of such proteins could
provide tools for investigating those biochemical mechanisms
related to the transfer of messages across the synaptic gaps
between nerve cells. Until recently, no protein with the right
credentials was known. Dr. Mobbs now thinks he has a potential
candidate.
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The distinct sequence ofnucleotide
bases to the left shows a classical
r~merymmary(rom~~bo~d
bases) which comprises the
consensus Estrogen Response
Element. A very similar sequence
appears to account for Gary
Romano's demonstration that
estradiol raises preproenkephalin
messenger RNA I~els in specific
hypothalamic neurons. Lab
members now focus on steroid
receptors as transcription factors,
capable of altering expression in
particular subsets of nerve cells
Genes controlling the manufacture
ofcertain hypothalamicchemicals,
neuropeptides, are of special
interest to Assistant Professor
Joseph T McCabe.
Pioneering a labeling methodfor
identifying RNA in brain tissue,
he is able to correlate synthesis of
vasopressin and oxytocin to levels
of other hormones and to
hypertension. Genetically
different rat and mouse strains
can usefully be compared, since
some have high bloodpressure and
others will not manufacture
vasopressin.
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receptor is sensitive to the chemical benzodiazepine, which
enhances the power of GABA to inhibit or dampen incoming
sensory signals. Working on reproductive behavior in the female
rat, Dr. Schwartz-Giblin demonstrated that progesterone
increases benzodiazepine binding, which in turn strengrhens
GABA power, but that the presence of estradiol weakens it.
Since the receptivity of the female to male stimulation peaks
at a point in the esrrus cycle when estrogen levels dip but
progesterone levels remain high, the data indicated that proges-
terone acted via benzodiazepine receptors to regulate the inten-
sity of the signals entering the spinal cord.
Dr. Schwartz-Giblin is also exploring the possibility that
estrogen plays a role in reducing pain and discomfort during
pregnancy. Other researchers have shown that pain and discom-
fort thresholds rise just before rats give birth. A similar increase
occurs in humans. Graduate fellow Gary Romano, who received
his Rockefeller Ph. D. in 1988, discovered that in the
hypothalamus, estrogen regulates the genetic expression of en-
kephalin, one of the body's natural opiates. Knowing that in
ABBREVIATIONS:
In this cross-section through the
rat hypothalamus, each dot shows
a nerve cell expressing the genefor
the progesterone receptor. With a
tritiated single-stranded DNA
probe, Gary Romano and
Postdoctoral Fellow Andrea
Lauber used in si tu hybridization
to find expression. Pretreatment
with estradiol turns this gene on,
whereas it reduces messenger
RNA levels for the estrogen
receptor itself.
ARC - arcuate nucleus
OM - dorsomedial nucleus
FX- fornix
ME - median eminence
III - third ventricle
VM- ventromedial nucleus of
hypothalamus
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Drs. Susan Schwartz-Giblin and Lee Ming Kow are two veteran
members of the laboratory whose work in neuroendocrinology
is opening windows on such problems as epilepsy, pain, and
drug side effects. Both are electrophysiologists who use record-
ings of electrical activity in neurons to study hormonal effects.
Dr. Schwartz-Giblin is particularly interested in steroid hor-
mone effects on the spinal cord. Even though most estrogen-
collecring cells in the nervous system are located in the
hypothalamus, a few are found in the spinal cord, in a region
where primary sensory nerve fibers come in and their signals
are processed. Dr. Schwartz-Giblin says she "couldn't help but
be struck by the evidence that these cells in the spinal cord
seemed to be strategically located for interaction with a class
of neurons that bind a chemical known as GABA."
In earlier research she had shown that GABA-binding cells
are found in almost every area of the brain and that GABA can
act as an inhibitory transmitter. One component of the GABA
UBIQUITOUS GABA AND
VERSATILE PEPTIDES
In his search he has been working with pairs of female rats
from which the ovaries have been removed. Both rats in a pair
are injected in the hypothalamus with radioactively labeled
protein precursors; one of them also receives an estradiol implant.
Dr. Mobbs then analyzes tissue from several brain regions of
each rat, using an intricate technique by which proteins are
separated according to molecular weight and electrical charge,
and imaged as spots on specially treated photographic film.
He has found a protein that almost always appears in the
hypothalamus and midbrain of rats given estradiol, but rarely
in rats nor given an infusion of the hormone. All the evidence
suggests that estradiol causes the protein to appear in the
hypothalamus; from there it is transported to the midbrain.
"It is the only protein out of the hundreds examined to meet
this test," he says. Now he is investigating the unanswered
questions: What is the function of this protein? Can we clone it?
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LHRH hormone-expressing cells
migratingfrom their origin in the
tip of the nose, across the nasa!
septum, and toward the brain
(top ofphoto) where they wi!!find
their final destinatiom from
which they will function. This
finding by Marlene Schwanze!-
Fukuda is the first example of
nerve cells expressing a specific
neuropeptide and moving into the
brain during its development.
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the spinal cord the receptors for enkephalin and dynorphin,
another opioid, are found parallel to estrogen cells, Dr. Schwartz-
Giblin intends to see whether estrogen has an effect on the
messenger RNA molecules that carry genetic instructions for
producing these painkillers.
Another project of interest is a follow-up study about the
effects of sex steroids on seizures she and Dr, Pfaff reported
recently. The two colleagues found that estrogen protects rats
against seizures induced by picrotoxin, a chemoconvulsant that
blocks GABA synaptic transmission. "What we know is that
all drugs given to control seizures, for example the barbiturates,
act through the GABA system," Dr. Schwartz-Giblin points
out. "So here we are back again to having to figure Out an
interaction between steroid hormones and GABA."
Dr. Kow, who has made important contributions to the
technique of recording electrical signals in vitro, is using his
expertise to study neuropeptides_ These include opioids, such
as enkephalin, hormones such as oxytocin, which speeds the
emergence of the fetus during labor, and the antidiuretic
vasopreSSln .
Before peptides were studied thoroughly in the nervous sys-
tem, rhey were thought to be just another category of neuro-
transmitter. Now, scientists like Dr. Kow are demonstrating
that a neuropeptide can be involved in a variety of biological
actions beyond simple transmission. By a much slower process
called modulation, neuropeptides markedly alter responses of
neurons to a classical rransmitter such as norepinephrine.
In a study investigating feeding behavior in rats, Dr. Kow
recorded the electrical activity of hypothalamic neurons treated
with TRH, a hormone involved in the regulation of food intake.
His findings showed that the peptide can reduce feeding by
modulating responses to the neurotransmitters norepinephrine
and serotonin.
"It's a whole new ball game," says Dr. Pfaff in describing the
change in viewpoint that Dr. Kow and other researchers' work
has brought about. Because modulation in the brain is widely
in.....olved in the peptide regulation of neural and endocrine
function, Drs. Kow and Pfaff maintain that "analyzing modula-
tory effects will help not only in rhe dissection of molecular
mechanisms, but also in the development of drugs thar interaet
with peptide-responsive neural systems." Dr, Kow's data illus-
trate that peptides can have prolonged actions on neurons, as
opposed to the rapid short-term actions of neurotransmitter-
active drugs which are often accompanied by unwelcome side
effects.
CELLS INVADING THE BRAIN
Surprise, be it frustrating or exhilarating, is an inevitable ingre-
dient of research. One of the most surprising recent discoveries
of the Pfaff laboratory was made by Marlene Schwanzel-Fukuda.
It concerned neurons that produce the peptide LHRH. LHRH
interacts with the pituitary gland, which in turn controls
testosterone production in developing vertebrates. Testosterone
plays a key role in the growrh of male sex characteristics and
the production of sperm.
''As little as a year ago," Dr. Pfaff says, "everybody would
have assumed that LHRH neurons are born in the brain." But
Dr. Schwanzel-Fukuda discovered that LHRH cells are formed
in an area at the tip of the nose called the olfactory placode
and actually travel from there through the nose into the bottom
of the brain, eventually to reach the hypothalamus.
Dr. Schwanzel-Fukuda believes her discovery may help explain
Kallmann's syndrome, a relatively rare genetic disease in humans
that inhibits sexual development in males and females by arrest-
ing normal development of testes or ovaries.
Chatting in his office or in introducing his colleagues, Dr.
Pfaff communicates his excitement about the group's work and
the scientific and practical promises of neurobiology_ "Recently,
it seems findings have been tumbling into our laps," he says.
"We've been lucky in thar we've been able to incorporate many
techniques of molecular endocrinology into our studies. But
these days, for discoveries in molecular brain research, it's just
a matter of being there." 0
